How Much Does Metformin Cost in California in 2026?

California Retail Cash Prices for Metformin

The average cash price for a 30-day supply of generic metformin across California retail pharmacies sits at approximately $8 per month in 2026, well below the manufacturer list price of roughly $40. Prices range from $3 at warehouse clubs like Costco to $12 at some independent pharmacies, depending on the specific formulation and tablet strength.

This price stability reflects metformin's status as one of the oldest and most widely manufactured diabetes drugs on the market. The FDA first approved metformin in the United States in 1994 under the brand name Glucophage (FDA label), and dozens of generic manufacturers now produce it. Competition among these manufacturers keeps prices suppressed.

Immediate-release tablets (500 mg, 850 mg, 1 to 000 mg) tend to cost $1 to $3 less per month than extended-release (ER) formulations. A patient filling metformin 500 mg IR twice daily at a California CVS or Walgreens without any insurance or discount card can expect to pay between $4 and $9. The ER version of the same total daily dose typically runs $6 to $12. Price differences between Northern and Southern California pharmacies are minimal, rarely exceeding $2 for the same NDC code.

The landmark UKPDS 34 trial (N=1,704) demonstrated that metformin reduced diabetes-related mortality by 42% in overweight patients with type 2 diabetes compared to conventional dietary therapy alone (Lancet 1998). That level of clinical benefit at single-digit monthly cost makes metformin one of the highest-value drugs in the entire U.S. formulary. The American Diabetes Association (ADA) continues to recommend metformin as first-line pharmacotherapy for type 2 diabetes in its 2024 Standards of Care (ADA Standards of Care).

Medi-Cal Coverage for Metformin

Medi-Cal, California's Medicaid program, covers metformin with prior authorization. For most patients, the copay is $0 to $1 per prescription fill, and prior authorization approval is routine for diagnoses of type 2 diabetes or prediabetes.

Prior authorization requirements exist primarily as a formulary management tool. Prescribers submit a request confirming the diagnosis and indicating that metformin is clinically appropriate. Approval turnaround is typically 24 to 72 hours. Medi-Cal managed care plans (including LA Care, Health Net, Molina, and CalOptima) each maintain their own formularies, but all currently list at least one metformin formulation as a covered generic.

For patients with prediabetes, Medi-Cal coverage of metformin may require additional documentation. The Diabetes Prevention Program (DPP) trial showed that metformin reduced progression from prediabetes to type 2 diabetes by 31% over 2.8 years compared to placebo (DPP, NEJM 2002). Despite this evidence, some Medi-Cal managed care plans still classify prediabetes as an off-label indication and require the prescriber to submit clinical notes supporting the prescription.

California expanded Medi-Cal eligibility in recent years to include undocumented adults, which means a broader population now has access to $0-copay metformin. Patients who are newly eligible should confirm enrollment with their managed care plan and request a formulary check before their first pharmacy visit. Delays most often occur when the managed care assignment has not yet propagated to the pharmacy system.

Insurance and Copay Costs Across California Plans

Most commercial insurance plans in California place metformin on Tier 1, the preferred generic tier. Typical copays fall between $0 and $10 for a 30-day supply, and many high-deductible health plans (HDHPs) exempt metformin from the deductible entirely under preventive drug coverage rules.

Covered California marketplace plans follow a standardized benefit design. Bronze, Silver, Gold, and Platinum tiers all cover generic metformin, though copay amounts differ by metal level. A Silver plan enrollee typically pays $5 to $10, while a Platinum enrollee often pays $0 to $3. The Kaiser Permanente plans available through Covered California consistently price generic metformin at $0 for members who use Kaiser pharmacies.

Large employer-sponsored plans from carriers like Anthem Blue Cross, Blue Shield of California, Aetna, and UnitedHealthcare also place metformin on Tier 1. For patients on these plans, the out-of-pocket cost is almost always less than the cash price. The Endocrine Society's 2024 clinical practice guideline reaffirms metformin as the initial pharmacologic agent for most adults with type 2 diabetes, noting its favorable cost profile and extensive safety record spanning over 60 years of global use (Endocrine Society).

One scenario where insurance may not reduce cost below cash price: patients enrolled in plans with flat copays of $15 or $20 for generics. These patients should compare their copay to the GoodRx or RxSaver price and use whichever is lower. California pharmacies are legally permitted to process a prescription through a discount card rather than insurance if the patient requests it.

Discount Programs and Savings Cards

Several pathways exist to reduce metformin costs below standard cash prices in California. Free discount cards from platforms like GoodRx, RxSaver, and SingleCare regularly bring the price to $3 to $6 for a 30-day supply of immediate-release metformin at chains including CVS, Walgreens, Rite Aid, Walmart, and Costco.

Walmart and Costco both include metformin on their $4 generic lists. Costco does not require a membership to use the pharmacy, a detail many California residents overlook. Mark Cuban's Cost Plus Drugs prices metformin at manufacturer cost plus a 15% margin plus a $5 pharmacy fee, which typically lands between $3 and $5 for a 30-day supply.

California-specific programs add another layer. The California Department of Health Care Services (DHCS) administers the 340B Drug Pricing Program at qualifying federally qualified health centers (FQHCs) statewide. Patients seen at an FQHC can access metformin at 340B pricing, which often means $0 to $2 per fill regardless of insurance status.

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association, has stated: "Metformin remains the cornerstone of type 2 diabetes treatment precisely because it combines strong clinical efficacy with accessibility that few other medications can match" (ADA, Diabetes Care 2024). That statement holds especially true in California, where the overlap of discount programs, 340B pricing, and Medi-Cal expansion creates multiple avenues to obtain the drug at minimal cost.

Compounded Metformin in California: Legality and Access

Compounded metformin is legal in California through licensed 503A compounding pharmacies operating under the oversight of the California State Board of Pharmacy. These pharmacies can prepare custom metformin formulations, including liquid suspensions, flavored preparations, and combination compounds, based on a valid patient-specific prescription.

Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound medications for individual patients when a prescriber determines that a commercially available product does not meet the patient's clinical needs (FDA Compounding Policy). Common reasons for compounding metformin include patients who cannot swallow tablets, patients who need a dose not commercially available, and patients with allergies to specific inactive ingredients in manufactured tablets.

Pricing for compounded metformin varies widely. Some 503A pharmacies price a 30-day supply at $15 to $40, while others offer it at cost as part of membership-based pharmacy models. Insurance coverage of compounded medications is inconsistent. Most commercial plans and Medi-Cal do not cover compounded metformin unless the prescriber documents medical necessity and the plan grants an exception.

California's Board of Pharmacy conducts regular inspections of 503A facilities and maintains a public database of licensed compounding pharmacies. Patients can verify a pharmacy's license status through the board's online lookup tool before filling a compounded prescription.

Telehealth Prescribing of Metformin in California

Telehealth prescribing of metformin is fully legal in California. State law permits licensed physicians, nurse practitioners, and physician assistants to prescribe metformin via synchronous video or audio-only visits, and the prescription can be transmitted electronically to any California pharmacy.

California Assembly Bill 32 (2021) made permanent many of the telehealth flexibilities originally enacted during the COVID-19 public health emergency. For metformin specifically, telehealth prescribing is straightforward because the drug is not a controlled substance and does not require an in-person physical exam under California Medical Board guidelines.

Multiple telehealth platforms operating in California now offer metformin prescriptions as part of diabetes management, weight management, or longevity-focused care programs. Visit costs range from $0 (for patients with insurance that covers telehealth) to $50 to $100 for cash-pay consultations. Some platforms bundle the prescription, lab orders, and ongoing monitoring into a monthly subscription.

The American Association of Clinical Endocrinology (AACE) 2023 consensus statement notes that remote monitoring combined with telehealth follow-up can improve metformin adherence and glycemic outcomes, particularly for patients in rural California counties where endocrinology access is limited (AACE Consensus Statement). Fresno, Kern, and Tulare counties each have fewer than 3 endocrinologists per 100,000 residents, making telehealth a practical necessity rather than a convenience for many patients.

Generic vs. Brand-Name Metformin Pricing in California

Brand-name Glucophage and Glucophage XR are still technically available but rarely dispensed. Cash price for brand-name metformin exceeds $200 per month in California, compared to $4 to $12 for generic equivalents. No clinical evidence supports superior efficacy of the brand-name product.

The FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (the "Orange Book") rates all currently marketed generic metformin products as "AB-rated" to the reference listed drug, meaning they are considered therapeutically equivalent and fully substitutable at the pharmacy level (FDA Orange Book).

A practical note for California patients: if a prescriber writes "Glucophage" on the prescription and does not check "Dispense as Written," the pharmacist will automatically substitute the generic. California Business and Professions Code Section 4073 requires pharmacists to dispense the generic equivalent unless the prescriber or patient specifically requests the brand.

Extended-release formulations deserve a mention. In 2020, the FDA requested recalls of certain metformin ER products due to NDMA (N-nitrosodimethylamine) levels above acceptable limits (FDA NDMA in Metformin). Those specific lots have been removed from the market, and current ER products meet FDA safety standards. Patients who switched away from metformin ER during the 2020 recalls can safely return to it.

How to Get the Lowest Price on Metformin in California

The cheapest path depends on your insurance status. Medi-Cal enrollees pay $0 to $1. Commercially insured patients with Tier 1 coverage pay $0 to $10. Uninsured patients should use a discount card at Costco or Walmart, where 30-day pricing consistently lands at $3 to $4.

For 90-day supplies, mail-order pharmacies often reduce per-unit cost further. Amazon Pharmacy, Mark Cuban Cost Plus Drugs, and Kaiser mail-order (for members) all offer 90-day metformin supplies for $6 to $12 total. Patients filling at retail pharmacies should always ask the pharmacist to compare the insurance copay against the discount card price before processing the claim.

The CDC's National Diabetes Statistics Report estimates that 3.9 million California adults have diagnosed diabetes and another 1.5 million have undiagnosed diabetes (CDC Diabetes Data). For the majority of these patients, metformin will be part of their treatment regimen, and the difference between paying $8 per month and $3 per month compounds into meaningful savings over years of continuous use.